プレシジョン医療における人工知能の世界市場規模調査＆予測、技術別、部品別、治療用途別、地域別分析、2023～2030年

精密医療における人工知能の世界市場は、2022年に約17億8,000万米ドルと評価され、2023～2030年の予測期間中に25.54％以上の健全な成長率で成長すると予測されています。

精密医療における人工知能とは、個々の患者に合わせた治療や介入を行うために、大規模な生物学的データや臨床データを分析する高度な計算技術や機械学習アルゴリズムを応用することを指します。精密医療は、診断、治療選択、治療結果を最適化するために、各患者に固有の遺伝子、分子、臨床的特徴を考慮することを目的としています。精密医療市場における人工知能市場は、個別化医療に対する需要の高まりやデジタルヘルスデータへのアクセシビリティの向上などの要因により拡大しています。その結果、精密医療における人工知能の需要は、予測期間2023～2030年の間に国際市場で徐々に増加しています。

人工知能アルゴリズムは、患者データを分析して個人が特定の治療にどのように反応するかを予測することができ、臨床医が最も効果的で害の少ない介入策を選択するのに役立ちます。この個別化されたアプローチは治療成果を高め、副作用のリスクを低減します。Statistaによると、個別化医療の世界市場は2020年に2兆2,100億米ドルを占め、2022年には2兆7,700億米ドルに達します。精密医療市場における人工知能市場を牽引するもう1つの重要な要因は、デジタルヘルスデータに対する需要の高まりです。人工知能の学習モデルは、デジタルヘルスデータ内の複雑なパターンや関係を分析することで、診断能力を高めることができます。これにより、疾病の早期かつ正確な発見につながり、タイムリーな介入とより良い転帰が可能になります。また、Statistaによると、世界のデジタルヘルス市場は2020年に2,160億米ドルを占め、2025年には6,570億米ドルに達すると予測されています。さらに、電子カルテに向けた政府の戦略的な取り組みや、精密医療における人工知能に関連する技術的な進歩は、予測期間中に市場に有利な成長機会をもたらすと予測されています。しかし、精密医療の高い市場開拓コストと言語アルゴリズムによる技術的な複雑さは、2023～2030年の予測期間を通じて市場全体の成長を阻害することになると考えられます。

精密医療における人工知能の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、患者の健康関連のデジタル情報データセットの増加と、同地域におけるNVIDIA Corporation、International Business Machines Corporation、Microsoft Corporationを含む人工知能の主要市場参入企業の存在感の高まりにより、2022年の市場を独占しました。大規模なデータセットを分析することで、新たなバイオマーカーや遺伝子と疾患との関連性を発見することができます。この情報は、精密医療アプローチの継続的な改良に貢献します。この地域の圧倒的な実績は、精密医療における人工知能の全体的な需要を促進すると予想されます。さらに、欧州は、医療支出の増加や同地域における政府のイニシアチブの増加などの要因により、予測期間中に最も急速に成長すると予想されます。AI主導の技術によって患者の遠隔モニタリングが可能になり、医療プロバイダーは個人の健康状態をリアルタイムで追跡できるようになります。これにより、頻繁に病院を受診する必要性を減らし、医療費を削減すると同時に、個人に合ったケアを提供することができます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 精密医療における人工知能の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 精密医療における人工知能の世界市場力学

• 精密医療における人工知能市場の影響分析（2020～2030年）
  • 市場促進要因
    • 個別化医療に対する需要の高まり
    • デジタルヘルスデータに対する需要の増加
  • 市場の課題
    • 精密医療の開発コストの高さ
    • 言語アルゴリズムの技術的複雑さ
  • 市場機会
    • 電子カルテに向けた政府の戦略的イニシアティブ
    • 精密医療における人工知能に関連する技術の進歩

第4章 世界の精密医療における人工知能市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 低価格
  • 社会
  • 技術
  • 環境
  • 法律
• 主要投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 精密医療における人工知能の世界市場：技術別

• 市場スナップショット
• 精密医療における人工知能の世界市場：技術別、実績・ポテンシャル分析
• 精密医療における人工知能の世界市場：技術別、推定・予測 2020～2030年
• 精密医療における人工知能市場、サブセグメント分析
  • 機械学習
  • クエリー手法
  • ディープラーニング
  • コンテキストアウェア処理
  • 自然言語処理

第6章 精密医療における人工知能の世界市場：部品別

• 市場スナップショット
• 精密医療における人工知能の世界市場：部品別、実績・ポテンシャル分析
• 精密医療における人工知能の世界市場：部品別、推定・予測、2020～2030年
• 精密医療における人工知能市場、サブセグメント分析
  • ハードウェア
  • ソフトウェア
  • サービス

第7章 精密医療における人工知能の世界市場：治療用途別

• 市場スナップショット
• 精密医療における人工知能の世界市場：治療用途別、実績・ポテンシャル分析
• 精密医療における人工知能の世界市場：治療用途別、2020～2030年推定・予測
• 精密医療における人工知能市場、サブセグメント分析
  • 腫瘍学
  • 神経学
  • 循環器
  • 呼吸器
  • その他

第8章 精密医療における人工知能の世界市場、地域分析

• 主要国
• 主要新興国
• 精密医療における人工知能市場、地域別市場スナップショット
• 北米
  • 米国
    • 技術別、推定・予測、2020～2030年
    • 部品別、推定・予測、2020～2030年
    • 治療用途別、推定・予測、2020～2030年
  • カナダ
• 欧州の精密医療における人工知能市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋の精密医療における人工知能市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカの精密医療における人工知能市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Novo Nordisk A/S
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
  • GE Healthcare
  • Intel Corporation
  • NVIDIA Corporation
  • Microsoft Corporation
  • Alphabet Inc.
  • International Business Machines Corporation
  • BioXcel Therapeutics Inc.
  • Enlitic Inc.
  • Sensely Inc.

第10章 調査プロセス

• 調査プロセス
  • データ鉱業
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Artificial Intelligence (AI) in Precision Medicine Market, report scope
• TABLE 2.Global Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by Technology 2020-2030 (USD Billion)
• TABLE 4.Global Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by Component 2020-2030 (USD Billion)
• TABLE 5.Global Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by Therapeutic Application 2020-2030 (USD Billion)
• TABLE 6.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Artificial Intelligence (AI) in Precision Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Artificial Intelligence (AI) in Precision Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Artificial Intelligence (AI) in Precision Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Artificial Intelligence (AI) in Precision Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Artificial Intelligence (AI) in Precision Medicine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Artificial Intelligence (AI) in Precision Medicine Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Artificial Intelligence (AI) in Precision Medicine Market
• TABLE 71.List of primary sources, used in the study of global Artificial Intelligence (AI) in Precision Medicine Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Artificial Intelligence (AI) in Precision Medicine Market, research methodology
• FIG 2.Global Artificial Intelligence (AI) in Precision Medicine Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Artificial Intelligence (AI) in Precision Medicine Market, key trends 2022
• FIG 5.Global Artificial Intelligence (AI) in Precision Medicine Market, growth prospects 2023-2030
• FIG 6.Global Artificial Intelligence (AI) in Precision Medicine Market, porters 5 force model
• FIG 7.Global Artificial Intelligence (AI) in Precision Medicine Market, pest analysis
• FIG 8.Global Artificial Intelligence (AI) in Precision Medicine Market, value chain analysis
• FIG 9.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Artificial Intelligence (AI) in Precision Medicine Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Artificial Intelligence (AI) in Precision Medicine Market, regional snapshot 2020 & 2030
• FIG 15.North America Artificial Intelligence (AI) in Precision Medicine Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Artificial Intelligence (AI) in Precision Medicine Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Artificial Intelligence (AI) in Precision Medicine Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Artificial Intelligence (AI) in Precision Medicine Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Artificial Intelligence (AI) in Precision Medicine Market is valued at approximately USD 1.78 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 25.54% over during the forecast period 2023-2030. Artificial Intelligence (AI) in Precision Medicine refers to the application of advanced computational techniques and machine learning algorithms to analyze large-scale biological and clinical data in order toto tailor medical treatments and interventions to individual patients. Precision Medicine aims to take into account the unique genetic, molecular, and clinical characteristics of each patient to optimize diagnosis, treatment selection, and therapeutic outcomes. The Artificial Intelligence (AI) in the Precision Medicine market Market is expanding because of factors such as rising demand for personalized medications and increasing accessibility to digital health data. As a result, the demand of for Artificial Intelligence (AI) in Precision Medicine has progressively increased in the international market during the forecast period 2023-2030.

Artificial intelligence algorithms can analyze patient data to predict how individuals is are going to respond to specific treatments, helping clinicians choose the most effective and least harmful interventions. This personalized approach enhances treatment outcomes and reduces the risk of adverse reactions. According to the Statista, the global market for personalized medicine accounts accounted for USD 2210 billion in 2020 and reached up to USD 2770 billion in 2022. Another important factor that drives the Artificial Intelligence (AI) in the Precision Medicine market Market is the increasing demand for digital health data. Artificial intelligence learning models can enhance diagnostic capabilities by analyzing complex patterns and relationships within digital health data. This can lead to earlier and more accurate detection of diseases, allowing for timely intervention and better outcomes. In addition, as per Statista, the global digital health market accounts for USD 216 billion in 2020 and is projected to reach up to USD 657 billion by the year 2025. Moreover, strategic government initiatives towards electronic health records and technological advancements associated with Artificial Intelligence (AI) in Precision Medicine is are anticipated to create a lucrative growth opportunity opportunities for the market over the forecast period. However, the high development cost of precision medicine and technical complexities with language algorithms is are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Artificial Intelligence (AI) in Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to growing patient health-related digital information datasets and the increasing presence of key market players from artificial intelligence including NVIDIA Corporation, International Business Machines Corporation, and Microsoft Corporation in the region. Analyzing large datasets can lead to the discovery of new biomarkers and genetic associations with diseases. This information contributes to the continuous refinement of precision medicine approaches. The region's dominant performance is anticipated to propel the overall demand of for Artificial Intelligence (AI) in Precision Medicine. Furthermore, Europe is expected to grow fastest during over the forecast period, owing to factors such as rising healthcare spending and increasing government initiatives in the region. AI-driven technologies can enable remote monitoring of patients, allowing healthcare providers to track individuals' health in real-timereal time. This can reduce the need for frequent hospital visits, lowering healthcare costs while still providing personalized care.

Major market player included in this report are:

• Novo Nordisk A/S
• GE Healthcare
• Intel Corporation
• NVIDIA Corporation
• Microsoft Corporation
• Alphabet Inc.
• International Business Machines Corporation
• BioXcel Therapeutics Inc.
• Enlitic Inc.
• Sensely Inc.

Recent Developments in the Market:

• In January 2024, Siemens Healthineers, in collaboration with the Indian Institute of Science (IISc) in Bangalore, has inaugurated the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory, a pioneering initiative in the realm of artificial intelligence (AI) for Precision Medicine. Dedicated to advancing the field of neuroimaging, the CDS collaborative laboratory is committed to the development of open-source AI tools. These tools are going to play a crucial role in automating the precise segmentation of pathological findings within neuroimaging data. The primary focus is on enhancing the accuracy of diagnoses for neurological diseases while concurrently analyzing their clinical impact at a broader population level. This collaborative endeavor is made possible through Siemens Healthineers' corporate social responsibility initiative. As part of this commitment, the initiative includes the provision of six M.Tech fellowships for women, with the overarching goal of fostering increased female representation in the field of artificial intelligence. This holistic approach not only promotes cutting-edge research and technological innovation in neuroimaging but also contributes to the broader societal objective of gender diversity and inclusion in AI.

Global Artificial Intelligence (AI) in Precision Medicine Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Technology, Component, Therapeutic Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology

• Machine Learning
• Querying Method
• Deep Learning
• Context-Aware Processing
• Natural Language Processing

By Component:

• Hardware
• Software
• Service

By Therapeutic Application:

• Oncology
• Neurology
• Cardiology
• Respiratory
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Artificial Intelligence (AI) in Precision Medicine Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Artificial Intelligence (AI) in Precision Medicine Market, by Technology, 2020-2030 (USD Billion)
  • 1.2.3.Artificial Intelligence (AI) in Precision Medicine Market, by Component, 2020-2030 (USD Billion)
  • 1.2.4.Artificial Intelligence (AI) in Precision Medicine Market, by Therapeutic Application, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Artificial Intelligence (AI) in Precision Medicine Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Artificial Intelligence (AI) in Precision Medicine Market Dynamics

• 3.1.Artificial Intelligence (AI) in Precision Medicine Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Rising demand for personalized medications
    • 3.1.1.2.Increasing demand for digital health data
  • 3.1.2.Market Challenges
    • 3.1.2.1.High development cost of precision medicine
    • 3.1.2.2.Technical complexities with language algorithms
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Strategic government initiatives towards electronic health records
    • 3.1.3.2.Technological advancements associated with Artificial Intelligence (AI) in Precision Medicine

Chapter 4.Global Artificial Intelligence (AI) in Precision Medicine Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Artificial Intelligence (AI) in Precision Medicine Market, by Technology

• 5.1.Market Snapshot
• 5.2.Global Artificial Intelligence (AI) in Precision Medicine Market by Technology, Performance - Potential Analysis
• 5.3.Global Artificial Intelligence (AI) in Precision Medicine Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 5.4.Artificial Intelligence (AI) in Precision Medicine Market, Sub Segment Analysis
  • 5.4.1.Machine Learning
  • 5.4.2.Querying Method
  • 5.4.3.Deep Learning
  • 5.4.4.Context-Aware Processing
  • 5.4.5.Natural Language Processing

Chapter 6.Global Artificial Intelligence (AI) in Precision Medicine Market, by Component

• 6.1.Market Snapshot
• 6.2.Global Artificial Intelligence (AI) in Precision Medicine Market by Component, Performance - Potential Analysis
• 6.3.Global Artificial Intelligence (AI) in Precision Medicine Market Estimates & Forecasts by Component 2020-2030 (USD Billion)
• 6.4.Artificial Intelligence (AI) in Precision Medicine Market, Sub Segment Analysis
  • 6.4.1.Hardware
  • 6.4.2.Software
  • 6.4.3.Service

Chapter 7.Global Artificial Intelligence (AI) in Precision Medicine Market, by Therapeutic Application

• 7.1.Market Snapshot
• 7.2.Global Artificial Intelligence (AI) in Precision Medicine Market by Therapeutic Application, Performance - Potential Analysis
• 7.3.Global Artificial Intelligence (AI) in Precision Medicine Market Estimates & Forecasts by Therapeutic Application 2020-2030 (USD Billion)
• 7.4.Artificial Intelligence (AI) in Precision Medicine Market, Sub Segment Analysis
  • 7.4.1.Oncology
  • 7.4.2.Neurology
  • 7.4.3.Cardiology
  • 7.4.4.Respiratory
  • 7.4.5.Others

Chapter 8.Global Artificial Intelligence (AI) in Precision Medicine Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Artificial Intelligence (AI) in Precision Medicine Market, Regional Market Snapshot
• 8.4.North America Artificial Intelligence (AI) in Precision Medicine Market
  • 8.4.1.U.S. Artificial Intelligence (AI) in Precision Medicine Market
    • 8.4.1.1.Technology breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Component breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.Therapeutic Application breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Artificial Intelligence (AI) in Precision Medicine Market
• 8.5.Europe Artificial Intelligence (AI) in Precision Medicine Market Snapshot
  • 8.5.1.U.K. Artificial Intelligence (AI) in Precision Medicine Market
  • 8.5.2.Germany Artificial Intelligence (AI) in Precision Medicine Market
  • 8.5.3.France Artificial Intelligence (AI) in Precision Medicine Market
  • 8.5.4.Spain Artificial Intelligence (AI) in Precision Medicine Market
  • 8.5.5.Italy Artificial Intelligence (AI) in Precision Medicine Market
  • 8.5.6.Rest of Europe Artificial Intelligence (AI) in Precision Medicine Market
• 8.6.Asia-Pacific Artificial Intelligence (AI) in Precision Medicine Market Snapshot
  • 8.6.1.China Artificial Intelligence (AI) in Precision Medicine Market
  • 8.6.2.India Artificial Intelligence (AI) in Precision Medicine Market
  • 8.6.3.Japan Artificial Intelligence (AI) in Precision Medicine Market
  • 8.6.4.Australia Artificial Intelligence (AI) in Precision Medicine Market
  • 8.6.5.South Korea Artificial Intelligence (AI) in Precision Medicine Market
  • 8.6.6.Rest of Asia Pacific Artificial Intelligence (AI) in Precision Medicine Market
• 8.7.Latin America Artificial Intelligence (AI) in Precision Medicine Market Snapshot
  • 8.7.1.Brazil Artificial Intelligence (AI) in Precision Medicine Market
  • 8.7.2.Mexico Artificial Intelligence (AI) in Precision Medicine Market
• 8.8.Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market
  • 8.8.1.Saudi Arabia Artificial Intelligence (AI) in Precision Medicine Market
  • 8.8.2.South Africa Artificial Intelligence (AI) in Precision Medicine Market
  • 8.8.3.Rest of Middle East & Africa Artificial Intelligence (AI) in Precision Medicine Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1. Novo Nordisk A/S
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.GE Healthcare
  • 9.3.3.Intel Corporation
  • 9.3.4.NVIDIA Corporation
  • 9.3.5.Microsoft Corporation
  • 9.3.6.Alphabet Inc.
  • 9.3.7.International Business Machines Corporation
  • 9.3.8.BioXcel Therapeutics Inc.
  • 9.3.9.Enlitic Inc.
  • 9.3.10.Sensely Inc.

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption